Acorah Software Products - Accounts Production 19.3.600 true true 31 March 2025 1 April 2024 false true No description of principal activity 1 April 2025 31 March 2026 31 March 2026 05761899 Dr D Griffiths Mrs S Griffiths iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 05761899 2025-03-31 05761899 2026-03-31 05761899 2025-04-01 2026-03-31 05761899 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 05761899 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 05761899 frs-bus:Micro-entities 2025-04-01 2026-03-31 05761899 frs-bus:EntityHasNeverTraded 2025-04-01 2026-03-31 05761899 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 05761899 frs-bus:Director1 2025-04-01 2026-03-31 05761899 frs-bus:Director2 2025-04-01 2026-03-31 05761899 2024-03-31 05761899 2025-03-31 05761899 2024-04-01 2025-03-31
Registered number: 05761899
The Endometriosis Centre Limited
Financial Statements
For The Year Ended 31 March 2026
Balance Sheet
Registered number: 05761899
2026 2025
£ £
Current assets 1 1
NET CURRENT ASSETS 1 1
TOTAL ASSETS LESS CURRENT LIABILITIES 1 1
NET ASSETS 1 1
CAPITAL AND RESERVES 1 1

Notes

1. General Information
The Endometriosis Centre Limited is a private company, limited by shares, incorporated in England & Wales, registered number 05761899 . The registered office is O-I Building, First Floor, The West Wing, Edinburgh Way, Harlow, Essex, CM20 2DB.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2025: 1)
2 1
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr D Griffiths
Director
13th August 2026